Evolve Private Wealth LLC purchased a new stake in shares of Agilent Technologies, Inc. (NYSE:A – Free Report) during the second quarter, according to the company in its most recent 13F filing with the SEC. The institutional investor purchased 6,386 shares of the medical research company’s stock, valued at approximately $850,000.
A number of other hedge funds and other institutional investors have also made changes to their positions in the stock. SHP Wealth Management acquired a new stake in Agilent Technologies during the 4th quarter worth about $26,000. Core Wealth Advisors LLC acquired a new position in shares of Agilent Technologies in the fourth quarter valued at about $26,000. Navalign LLC acquired a new position in shares of Agilent Technologies in the fourth quarter valued at about $27,000. MV Capital Management Inc. purchased a new position in shares of Agilent Technologies in the fourth quarter worth about $28,000. Finally, Entrust Financial LLC purchased a new position in shares of Agilent Technologies in the fourth quarter worth about $31,000.
Wall Street Analyst Weigh In
A number of equities research analysts recently commented on A shares. HSBC dropped their target price on Agilent Technologies from $180.00 to $165.00 and set a “buy” rating on the stock in a research report on Wednesday, June 3rd. Barclays lifted their price objective on shares of Agilent Technologies from $145.00 to $150.00 and gave the company an “overweight” rating in a research note on Wednesday, June 24th. Robert W. Baird upped their price objective on shares of Agilent Technologies from $155.00 to $156.00 and gave the company an “outperform” rating in a report on Tuesday, May 26th. Weiss Ratings upgraded shares of Agilent Technologies from a “hold (c-)” rating to a “hold (c)” rating in a research note on Tuesday, June 2nd. Finally, Wall Street Zen raised shares of Agilent Technologies from a “hold” rating to a “buy” rating in a report on Sunday, August 2nd. Two research analysts have rated the stock with a Strong Buy rating, thirteen have issued a Buy rating and four have assigned a Hold rating to the company. According to MarketBeat, Agilent Technologies currently has a consensus rating of “Moderate Buy” and a consensus price target of $160.24.
Agilent Technologies Trading Up 0.2%
Shares of NYSE:A opened at $159.25 on Monday. The company has a current ratio of 2.10, a quick ratio of 1.62 and a debt-to-equity ratio of 0.43. Agilent Technologies, Inc. has a 12-month low of $108.35 and a 12-month high of $160.51. The business has a 50 day moving average of $137.57 and a two-hundred day moving average of $126.17. The company has a market capitalization of $44.98 billion, a PE ratio of 31.98, a PEG ratio of 2.80 and a beta of 1.25.
Agilent Technologies (NYSE:A – Get Free Report) last issued its quarterly earnings data on Wednesday, May 27th. The medical research company reported $1.49 EPS for the quarter, topping analysts’ consensus estimates of $1.41 by $0.08. The business had revenue of $1.83 billion for the quarter, compared to analysts’ expectations of $1.80 billion. Agilent Technologies had a net margin of 19.55% and a return on equity of 24.33%. The business’s revenue was up 10.0% on a year-over-year basis. During the same quarter last year, the company earned $1.31 EPS. Agilent Technologies has set its FY 2026 guidance at 6.000-6.100 EPS and its Q3 2026 guidance at 1.480-1.500 EPS. As a group, analysts forecast that Agilent Technologies, Inc. will post 6.05 EPS for the current year.
Agilent Technologies Company Profile
Agilent Technologies is a global provider of scientific instrumentation, consumables, software and services for laboratories across the life sciences, diagnostics and applied chemical markets. The company’s product portfolio includes analytical instruments such as liquid and gas chromatographs, mass spectrometers, spectroscopy systems, and laboratory automation solutions, together with reagents, supplies and informatics tools that support measurement, testing and data analysis workflows. Agilent also offers instrument maintenance, qualification and laboratory services designed to help customers improve productivity and comply with regulatory requirements.
Founded as a corporate spin-off from Hewlett‑Packard in 1999, Agilent has evolved through a combination of strategic restructuring and acquisitions to concentrate on life sciences, diagnostics and applied laboratories.
See Also
- Five stocks we like better than Agilent Technologies
- VIG, VYM, and VYMI: Which Vanguard Dividend ETF Is Right for You?
- 3 Closed-End Funds to Maximize Dividend Payments
- Rocket Lab’s Sell-Off Is Fading—Is It Finally Safe to Buy?
- $27 Billion in Buybacks: 3 Stocks Betting Their Strong Runs Aren’t Over
Want to see what other hedge funds are holding A? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Agilent Technologies, Inc. (NYSE:A – Free Report).
Receive News & Ratings for Agilent Technologies Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Agilent Technologies and related companies with MarketBeat.com's FREE daily email newsletter.
